Cargando…

An integrated bioinformatics analysis to dissect kinase dependency in triple negative breast cancer

BACKGROUND: Triple-Negative Breast Cancer (TNBC) is an aggressive disease with a poor prognosis. Clinically, TNBC patients have limited treatment options besides chemotherapy. The goal of this study was to determine the kinase dependency in TNBC cell lines and to predict compounds that could inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryall, Karen A, Kim, Jihye, Klauck, Peter J, Shin, Jimin, Yoo, Minjae, Ionkina, Anastasia, Pitts, Todd M, Tentler, John J, Diamond, Jennifer R, Eckhardt, S Gail, Heasley, Lynn E, Kang, Jaewoo, Tan, Aik Choon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682411/ https://www.ncbi.nlm.nih.gov/pubmed/26681397 http://dx.doi.org/10.1186/1471-2164-16-S12-S2

Ejemplares similares

Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast Cancer
por: Ionkina, Anastasia A., et al.
Publicado: (2017)

Systems Pharmacology-Based Approach of Connecting Disease Genes in Genome-Wide Association Studies with Traditional Chinese Medicine
por: Kim, Jihye, et al.
Publicado: (2018)

K-Map: connecting kinases with therapeutics for drug repurposing and development
por: Kim, Jihye, et al.
Publicado: (2013)

Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer
por: Klauck, Peter J., et al.
Publicado: (2018)

Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts
por: Lieu, Christopher H., et al.
Publicado: (2015)

Dual Pharmacological Targeting of the MAP Kinase and PI3K/mTOR Pathway in Preclinical Models of Colorectal Cancer
por: Pitts, Todd M., et al.
Publicado: (2014)

Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models
por: Davis, S. Lindsey, et al.
Publicado: (2015)

Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer
por: Pitts, Todd M., et al.
Publicado: (2016)

Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer
por: Pitts, Todd M., et al.
Publicado: (2020)

ATM and MET kinases are synthetic lethal with non-genotoxic activation of p53
por: Sullivan, Kelly D., et al.
Publicado: (2012)

From Bench to Bedside: Lessons Learned in Translating Preclinical Studies in Cancer Drug Development
por: Lieu, Christopher H., et al.
Publicado: (2013)

RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer
por: Tentler, John J., et al.
Publicado: (2020)

Systems biology approaches for advancing the discovery of effective drug combinations
por: Ryall, Karen A, et al.
Publicado: (2015)

Big Data Mining and Adverse Event Pattern Analysis in Clinical Drug Trials
por: Federer, Callie, et al.
Publicado: (2016)

A Phase I Dose‐Escalation Study of Linsitinib (OSI‐906), a Small‐Molecule Dual Insulin‐Like Growth Factor‐1 Receptor/Insulin Receptor Kinase Inhibitor, in Combination with Irinotecan in Patients with Advanced Cancer
por: Davis, S. Lindsey, et al.
Publicado: (2018)

Co-dependency of PKCδ and K-Ras: Inverse association with cytotoxic drug sensitivity in KRAS mutant lung cancer
por: Ohm, Angela M., et al.
Publicado: (2017)

Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer models
por: Capasso, Anna, et al.
Publicado: (2018)

IMPACT web portal: oncology database integrating molecular profiles with actionable therapeutics
por: Hintzsche, Jennifer D., et al.
Publicado: (2018)

PAGER 2.0: an update to the pathway, annotated-list and gene-signature electronic repository for Human Network Biology
por: Yue, Zongliang, et al.
Publicado: (2018)

An Inducible TGF-β2-TGFβR Pathway Modulates the Sensitivity of HNSCC Cells to Tyrosine Kinase Inhibitors Targeting Dominant Receptor Tyrosine Kinases
por: Kleczko, Emily K., et al.
Publicado: (2015)

Association of the epithelial-to-mesenchymal transition phenotype with responsiveness to the p21-activated kinase inhibitor, PF-3758309, in colon cancer models
por: Pitts, Todd M., et al.
Publicado: (2013)

Automatic Context-Specific Subnetwork Discovery from Large Interaction Networks
por: Saha, Ashis, et al.
Publicado: (2014)

Tumor P-Glycoprotein Correlates with Efficacy of PF-3758309 in in vitro and in vivo Models of Colorectal Cancer
por: Bradshaw-Pierce, Erica Lynn, et al.
Publicado: (2013)

ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer
por: Pilling, Amanda B., et al.
Publicado: (2018)

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer
por: Diamond, Jennifer R., et al.
Publicado: (2018)

WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma
por: Hartman, Sarah J., et al.
Publicado: (2021)

iCOSSY: An Online Tool for Context-Specific Subnetwork Discovery from Gene Expression Data
por: Saha, Ashis, et al.
Publicado: (2015)

Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies
por: Pozdeyev, Nikita, et al.
Publicado: (2016)

A Pilot Study of Biomedical Text Comprehension using an Attention-Based Deep Neural Reader: Design and Experimental Analysis
por: Kim, Seongsoon, et al.
Publicado: (2018)

Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model
por: Scott, Aaron J., et al.
Publicado: (2017)

A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer
por: Gurule, Natalia J., et al.
Publicado: (2021)

Systematic analysis of tumour cell-extracellular matrix adhesion identifies independent prognostic factors in breast cancer
por: Todd, Jason R., et al.
Publicado: (2016)

Bioinformatic tools for microRNA dissection
por: Akhtar, Most Mauluda, et al.
Publicado: (2016)

BRONCO: Biomedical entity Relation ONcology COrpus for extracting gene-variant-disease-drug relations
por: Lee, Kyubum, et al.
Publicado: (2016)

Bioinformatical dissection of fission yeast DNA replication origins
por: Masuda, Koji, et al.
Publicado: (2020)

Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities
por: Kleczko, Emily K., et al.
Publicado: (2018)

A survey of statistical software for analysing RNA-seq data
por: Gao, Dexiang, et al.
Publicado: (2010)

A short survey of computational analysis methods in analysing ChIP-seq data
por: Kim, Hyunmin, et al.
Publicado: (2011)

Long Term Storage of Dry versus Frozen RNA for Next Generation Molecular Studies
por: Seelenfreund, Eric, et al.
Publicado: (2014)

Electric scooter-related triple cervical artery dissection
por: Glynn, David, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5n20acmiu6k445fsg1npumfcnn